IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishTumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects.
De Simone, C., Perino, F., Caldarola, G., D'agostino, M., Peris, K., Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports, <<JOURNAL OF INTERNATIONAL MEDICAL RESEARCH>>, 2016; 44 (1_suppl): 67-71. [doi:10.1177/0300060515593250] [http://hdl.handle.net/10807/92635]
| Autori: | ||
| Titolo: | Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1177/0300060515593250 | |
| URL: | http://imr.sagepub.com/content/by/year | |
| Data di pubblicazione: | 2016 | |
| Abstract: | Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects. | |
| Lingua: | Inglese | |
| Rivista: | ||
| Citazione: | De Simone, C., Perino, F., Caldarola, G., D'agostino, M., Peris, K., Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports, <<JOURNAL OF INTERNATIONAL MEDICAL RESEARCH>>, 2016; 44 (1_suppl): 67-71. [doi:10.1177/0300060515593250] [http://hdl.handle.net/10807/92635] | |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2021